<div data-server-rendered="true" id="__nuxt"><div id="__layout"><div class="outer-container"><div class="content-container"> <div class="answer_container" style="min-height:calc(100vh - 54px);" data-v-0eba195e=""><div class="content_outer_container" data-v-0eba195e=""><div class="share_preview_container" data-v-0eba195e=""><div class="dialog_list" data-v-0eba195e=""><div class="dialog_item" data-v-0eba195e=""><div class="dialog_question fir_dialog_question" data-v-0eba195e=""><div class="question_con" data-v-0eba195e=""><h1 class="fir_question_content" data-v-0eba195e="">
                                    How does CANF's Q3 2023 performance compare to Q3 2022?
                                </h1> <div class="user_slot" data-v-0eba195e=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/default_aime_user.ec532c9.png" alt="user" class="avatar" data-v-0eba195e=""> <span class="user_desction" data-v-0eba195e="">
                                        
                                        4/7/2025 03:23pm
                                    </span></div></div></div> <div class="seo-text-answer" data-v-0eba195e="">Can-fite Biopharma (CANF) experienced a significant decline in its stock price in Q3 2023 compared to Q3 2022. The closing price for Q3 2023 was $2.65, which represents a 2.65% decrease from the previous quarter's closing price of $7.70. This indicates a substantial negative momentum for the stock in the recent period.


|code|Ticker|Name|Date|Closing Price|market_code|
|---|---|---|---|---|---|
|CANF|CANF.A|Can-fite Biopharma|20230926|2.59|170|


</div> <div class="dialog_answer" data-v-0eba195e=""><div class="dialog_content" data-v-0eba195e=""><div class="answer_content" data-v-0eba195e=""></div></div></div></div></div> </div></div></div> </div> <div class="extra-module" data-v-261d488f=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/recommend-logo.4f9ccc8.png" alt="right-logo" fetchpriority="high" class="recommend-logo-img" data-v-261d488f=""> <div class="recommend-part" data-v-7790c618="" data-v-261d488f=""><div class="recommend-query-card" data-v-8359219a="" data-v-7790c618=""><div class="title" data-v-8359219a=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/screener-recommend-icon.b007ca8.svg" alt="icon" data-v-8359219a=""> <span data-v-8359219a="">Aime finds your next big stock</span></div> </div> <div class="recommend-query-card" data-v-8359219a="" data-v-7790c618=""><div class="title" data-v-8359219a=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/stock-recommend-icon.77f1c78.svg" alt="icon" data-v-8359219a=""> <span data-v-8359219a="">Aime powers your decisions</span></div> </div></div> </div> <div class="container-mask" style="display:none;"></div></div></div></div><script>window.__NUXT__=(function(a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,A,B,C,D,E,F,G,H,I,J,K,L,M,N,O,P,Q,R,S,T,U,V,W,X,Y,Z,_,$,aa,ab,ac,ad,ae,af,ag,ah,ai,aj,ak,al,am,an,ao,ap,aq,ar,as,at,au,av,aw,ax,ay,az,aA,aB,aC,aD){return {layout:"default",data:[{noData:c,currentQuestion:j,textDescription:R,comeFrom:"AInvestShareLink",events:[],answerSource:p}],fetch:{},error:q,state:{sharePreviewModule:{loadJgySuccess:e,dialogRenderList:[{originAnswer:{input_media_info:[],session_round:f,agent_id:a,output_media_info:[],task_id:a,language:a,source:p,cache_builder:a,reply_action:"Answer",execute_mode:B,event_refresh_answer:a,param:"{\"entity_info\":{},\"add_info\":{\"ori_question\":\"How does CANF's Q3 2023 performance compare to Q3 2022?\"},\"event_list\":[],\"client_ip\":\"\",\"question\":\"How does CANF's Q3 2023 performance compare to Q3 2022?\",\"user_id\":\"dp21527247\",\"user_name\":\"\",\"trace_id\":\"33e25220-13ac-4423-bfc7-52d876697799\",\"session_id\":\"33e25220-13ac-4423-bfc7-52d876697799\",\"source\":\"ths_ainvest_lite_web\",\"input_type\":\"typewrite\"}",agent_info:[{info_type:S,query_type:g,text:"1 results found:\n|stock code|stock name|Last Price|Last Change|Closing Price[20230929]|\n|---|---|---|---|---|\n|CANF.A|Can-fite Biopharma|$1.47|-2.65%|$2.65|\n",query_data:{number:f,title:C,query_type:g,condition:a,model_sql:T,data_ext_params:{merge_repeat:c,expand_index:b,data_add:f,add_index:e}}},{info_type:S,query_type:g,text:"1 results found:\n|stock code|stock name|Last Price|Last Change|Closing Price[20220930]|\n|---|---|---|---|---|\n|CANF.A|Can-fite Biopharma|$1.47|-2.65%|$7.7|\n",query_data:{number:U,title:D,query_type:g,condition:a,model_sql:V,data_ext_params:{merge_repeat:c,expand_index:b,data_add:f,add_index:e}}}],answer_chain_name:W,agent_mode:X,native_answer:a,come_from:a,text_answer:R,trace_id:l,cost:12076,event_names:a,question:j,fallback_type:Y,input_type:Z,fall_back_reason:{fall_back_type:Y,risk_detail:{matched_words:[]}},session_id:l,first_return_cost:2874,cache_type:a,question_id:l,transfer_question:j,signal_type:"ON_COMPLETE",start_time:_,remote_svc:p,slots:[],answer_type:B,user_id:x,skill_name:E},renderList:[{type:"base_info",answer_path:"logs\u002FbaseInfo",logs:[],base_info:{trace_id:l,session_id:l,user_id:x,question:j,source:p,raw_question:j,version:"3.4.1",action_name:E,nlu:{entity:[{type:F,value:$,market:G}]},deep_research:c,deep_thinking:c,agent_mode:X},extra:{}},{answer_path:r,section:{id:s,info_texts:["Thinking"],show_type:t,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"begin"},logs:[],extra:{is_deep_research:c,deep_thinking:c}},{answer_path:r,section:{id:s,info_texts:["Querying Stock: CANF Closing Price in Q3 2023"],show_type:t,choice:[],result_page:{},tag_info_list:[],is_last:b,status:aa},logs:[],extra:{action:ab,action_input:C,thought:ac}},{answer_path:r,section:{id:s,info_texts:["Querying Stock: CANF Closing Price in Q3 2022"],show_type:t,choice:[],result_page:{},tag_info_list:[],is_last:b,status:aa},logs:[],extra:{action:ab,action_input:D,thought:ac}},{answer_path:d,section:{id:k,info_texts:[],show_type:h,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:k,info_texts:[],show_type:h,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:r,section:{id:s,info_texts:["Generating Answer"],show_type:t,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"ongoing"},logs:[],extra:{}},{answer_path:d,section:{id:m,info_texts:[],show_type:n,voice_txt:"Can",text_answer:ad,rich_text:ad,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:ae,info_texts:[],show_type:n,voice_txt:a,text_answer:a,rich_text:a,choice:[],result_page:{},tag_info_list:[{title:C,query_type:g,trace_data:a,index:f,model_sql:T,data_ext_params:{merge_repeat:c,expand_index:b,data_add:f,add_index:e},jump_type:af}],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:m,info_texts:[],show_type:n,voice_txt:a,text_answer:ag,rich_text:ag,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:ae,info_texts:[],show_type:n,voice_txt:a,text_answer:a,rich_text:a,choice:[],result_page:{},tag_info_list:[{title:D,query_type:g,trace_data:a,index:U,model_sql:V,data_ext_params:{merge_repeat:c,expand_index:b,data_add:f,add_index:e},jump_type:af}],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:m,info_texts:[],show_type:n,voice_txt:". This",text_answer:ah,rich_text:ah,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:k,info_texts:[],show_type:h,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:1001,info_texts:[],show_type:"fenshi",choice:[],result_page:{},tag_info_list:[{stock_info:{code:ai,market_id:G,name:H,domain:F},pos:e,section_id:m,txt:H,jump_type:"pos_fenshi"}],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:k,info_texts:[],show_type:h,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:k,info_texts:[],show_type:h,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:m,info_texts:[],show_type:n,voice_txt:"\n",text_answer:aj,rich_text:aj,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:k,info_texts:[],show_type:h,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:k,info_texts:[],show_type:h,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:k,info_texts:[],show_type:h,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:m,info_texts:[],show_type:ak,choice:[],result_page:{components:[{uuid:"c12dc358957c8407",config:{image:"https:\u002F\u002Flh-prod-mid-pub-newsf10.s3.amazonaws.com\u002Flogo\u002FCANF.png",marketTag:"AMEX",show_type_id:702,tradeClass:"closed",title:"K线图V2",showBottom:b,score:20,show_type:al,variety:F,scoreRuleNames:a,tradeStatus:"trading",codeName:y,klineDefaultType:"fs",title_config:{config:{display:b,display2:c,txt_style:e,url:a},data:{h1:am,h2:a},show_type:I}},data:{chunks_info:"[]",code_count:f,columns:[{index_name:J,key:J,label:"hq_code",source:K,type:i},{domain:L,feKey:M,index_name:M,key:M,label:J,origin_index:"stock code",source:K,type:i,unit:a},{domain:L,feKey:y,index_name:y,key:y,label:"name",origin_index:"stock name",source:K,type:i,unit:a},{feKey:z,index_name:z,key:z,label:"date",origin_index:z,type:"DATE"},{domain:L,feKey:N,index_name:N,key:N,label:a,source:a,timestamp:a,type:"DOUBLE",unit:"USD"},{index_name:an,key:an,type:i}],condition:"[{\"sonSize\":2,\"opName\":\"and\",\"relatedSize\":0},{\"sonSize\":0,\"indexName\":\"国际美股@stock code\",\"indexProperties\":[\"EQUAL CANF.A\"],\"indexPropertiesMap\":{\"EQUAL\":\"CANF.A\"},\"domain\":\"abs_国际美股领域\",\"relatedSize\":0},{\"sonSize\":0,\"indexName\":\"国际美股@Closing Price\",\"indexProperties\":[\"起始交易日期 20230926\",\"截止交易日期 20230926\"],\"indexPropertiesMap\":{\"起始交易日期\":\"20230926\",\"截止交易日期\":\"20230926\"},\"domain\":\"abs_国际美股领域\",\"relatedSize\":0}]",dataSize:f,datas:[{code:ai,Ticker:$,market_code:G,"Closing Price":2.59,Date:"20230926",Name:H}],meta:{extra:{}},row_count:f,status_code:e,status_msg:"ok"},category:"generic",chart_type:a,show_type:al,title_config:{config:{display:b,display2:c,txt_style:e,url:a},data:{h1:am,h2:a},show_type:I},support_refresh:b,data_config:{query:a,query_type:g,data_ext_params:{}}}],global:{query_type:g},page:{language:a,layout:{layout_data:"[{\"children\":[],\"showType\":\"kline3\",\"uuid\":\"c12dc358957c8407\"}]"},render_for:O},data_config:{query:a,query_type:g,data_ext_params:{}}},tag_info_list:[],is_last:c,uuid:"a298b69c-5794-484c-97f7-5b075811629b"},logs:[],extra:{}},{answer_path:d,section:{id:m,info_texts:[],show_type:n,voice_txt:a,text_answer:a,rich_text:a,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"extraInfo\u002FsourceLink",logs:[],extra:{span_id:a,link_id:a,source:a,link_text:a,link_param:a,link_ids:[]}},{answer_path:r,section:{id:s,info_texts:["Completed"],show_type:t,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"end"},logs:[],extra:{}},{answer_path:"suggest\u002Fquestions",section:{id:10002,info_texts:[],show_type:ak,choice:[{display_text:u,query_text:u,trace_info:{item_id:"d3267beef843132d059569d07dd8536f",item_type:o,item_name:u,rec_info:ao}},{display_text:v,query_text:v,trace_info:{item_id:"8b68a5af5b0198ab8ead730957454ecf",item_type:o,item_name:v,rec_info:ap}},{display_text:w,query_text:w,trace_info:{item_id:"7bfe889e96ecfdeb8ab0a74860048ed9",item_type:o,item_name:w,rec_info:aq}}],result_page:{components:[{show_type:"lowcode",title_config:{show_type:I,data:{h1:a,h2:a},config:{display:c,txt_style:e,type:"1",display2:c,url:a}},request_config:[{source_type:ar,related_name:as}],puuid:P,tag:a,category:"custom",uuid:at}],global:{urp_static_data:[{name:as,value:{status_code:e,columns:[{type:i,index_name:au,key:au},{type:i,index_name:av,key:av},{type:i,index_name:aw,key:aw},{type:i,index_name:ax,key:ax},{type:i,index_name:ay,key:ay}],datas:[{send_text:u,item_type:o,rec_info:ao,display_text:u,rec_reason:a},{send_text:v,item_type:o,rec_info:ap,display_text:v,rec_reason:a},{send_text:w,item_type:o,rec_info:aq,display_text:w,rec_reason:a}],dataSize:ar,status_msg:a}}],lowcode_type:"shunda",interface_request_list:[],lowcode_json:{stack:c,visible:b,childLimit:9999,label:az,type:"thslc\u002Fthslc-common-container",leaf:c,animate:[],version:"1.0.1",script:[],props:[],path:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Fkernel-thslc-resource\u002Fresource\u002Fainvest\u002F0Ae514cfA4\u002Fjs\u002F_thslc-common-container_1.0.1_index.js",isTransparent:b,style:{"background-color":a,"box-shadow":"0px 0px 0px",color:a,width:A,"min-height":"100%",position:aA,height:A},isMaterial:c,id:az,needTheme:c,hasEditor:c,packed:c,events:[],child:[{readmeUrl:"https:",stack:c,visible:b,customStyle:a,childLimit:e,label:"路径推荐",type:"iwencai\u002FrecommendList",leaf:b,version:"1.12.0",animate:[],url:Q,componentUuid:at,script:[{name:aB,id:20240320,content:"return {\r\n  created: function created() {\r\n    this.isActive = !Boolean(this.$parent.$parent.$parent.$parent.$parent.$parent.question);\r\n    var showId ='tkPanel_bottomTag';\r\n  this.buryPointId = showId;\r\n  }\r\n};"}],props:{recommendList:[],isTransparent:b,renderType:"blue"},path:Q,meta:{custom_editor_url:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Ffoiegras\u002FrecommendList\u002F1.12.0\u002FrecommendList@1.12.0editor.js",js_url:Q},style:{"background-color":a,margin:"-12px 0px -12px 0px",color:a,display:"block",width:A,position:aA,height:A},isMaterial:b,_id:19,id:aB,hasEditor:b,packed:c,events:[],isSetDefaultValue:b}]}},page:{layout:{layout_data:"[{\"uuid\":\"ztxxx06c0a024223920bbbeb1e0926\",\"showType\":\"lowcode\",\"children\":[]}]"},render_for:O,voice_txt:a,tracking_info:{},uuid:P},order:{is_auto:c,render_for:O,chart_type:"command",puuid:P}},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"suggest\u002Finputs",section:{id:10000,info_texts:[],show_type:"choice",choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"logs\u002Ftrace_debug",section:{id:1005,info_texts:[],show_type:h,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{action_name:E,with_paid_index:c,no_refresh_answer:c,answer_source:{agent_id:a,agent_name:a,execute_mode:B,answer_chain_name:W},is_deep_research:c,deep_thinking:c,create_time:1744010621290},is_last:b}],questionItem:{data:{qStr:j,encodeFlag:c,imageData:q,docsData:[],quoteData:q},tplType:"question"},events:aC,agentId:a,param:{entity_info:{},add_info:{ori_question:j},event_list:aC,client_ip:a,question:j,user_id:x,user_name:a,trace_id:l,session_id:l,source:p,input_type:Z}}],userId:x,userName:a,startTime:_,mobileType:a,comeFrom:a,textConstants:{},dialogContainer:q,endSignal:c,theme:"white",showTracePopup:c,traceListData:[],chatTraceTargetIndex:e,traceTableData:q,showMask:c}},serverRendered:b,routePath:"\u002Faime\u002Fshare\u002Fcanfs-q3-2023-performance-compare-q3-2022-6f68d4\u002F",config:{_app:{basePath:aD,assetsPath:aD,cdnURL:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Fiwc-aime-seo\u002F"}}}}("",true,false,"other\u002FopenAnswer",0,1,"intusstock","signal","STR","How does CANF's Q3 2023 performance compare to Q3 2022?",999,"33e25220-13ac-4423-bfc7-52d876697799",2001,"rich_text","llm_generated","ths_ainvest_lite_web",null,"progress\u002Fsearching_for",1000,"searching_for","How did CANF's revenue and earnings change from Q3 2022 to Q3 2023?","What are the analysts' expectations for CANF's Q4 2023 performance?","What were CANF's key financial metrics in Q3 2022?","dp21527247","Name","Date","auto","agent","CANF Closing Price in Q3 2023","CANF Closing Price in Q3 2022","review stocks","stock","170","Can-fite Biopharma","title1","code","fixed_index","abs_国际美股领域","Ticker","Closing Price","aigc","39196","\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Ffoiegras\u002FrecommendList\u002F1.12.0\u002FrecommendList@1.12.0index.js","Can-fite Biopharma (CANF) experienced a significant decline in its stock price in Q3 2023 compared to Q3 2022. The closing price for Q3 2023 was $2.65, which represents a 2.65% decrease from the previous quarter's closing price of $7.70. This indicates a substantial negative momentum for the stock in the recent period.\n\n\n|code|Ticker|Name|Date|Closing Price|market_code|\n|---|---|---|---|---|---|\n|CANF|CANF.A|Can-fite Biopharma|20230926|2.59|170|\n\n\n","query_data","select   stock_code,   closing_price from   ustock_market_data where   trading_date = date('2023y3q')   and interval = 'quarterly'   and stock_code = 'CANF.A'",2,"select   stock_code,   closing_price from   ustock_market_data where   trading_date = date('2022y3q')   and interval = 'quarterly'   and stock_code = 'CANF.A'","agent_common_v2\nagent-summary","normal_agent","NONE","typewrite",1744010609214,"CANF.A","thinking","Querying Stock","The user wants to compare the Q3 2023 performance of CANF with Q3 2022. I should focus on the Q3 2023 and Q3 2022 closing price data. I will use FinQuery for the data.","Can-fite Biopharma (CANF) experienced a significant decline in its stock price in Q3 2023 compared to Q3 2022. The closing price for Q3 2023 was $2.65, which represents a 2.65% decrease from the previous quarter's closing price of $7.70[^1]",2000,"data_query","[^2]",". This indicates a substantial negative momentum for the stock in the recent period.\n\n","CANF","\n``` visual\n{\"uuid\":\"a298b69c-5794-484c-97f7-5b075811629b\"}\n```\n","result_page","kline3","CANF Trend","market_code","2+679_496_21_554+0+0+33e25220-13ac-4423-bfc7-52d876697799+d3267beef843132d059569d07dd8536f+llm_generated+aimeTagAnalysis+0+0.08153482526540756+1","2+679_496_21_554+0+0+33e25220-13ac-4423-bfc7-52d876697799+8b68a5af5b0198ab8ead730957454ecf+llm_generated+aimeTagAnalysis+0+0.07285236567258835+2","2+679_496_21_554+0+0+33e25220-13ac-4423-bfc7-52d876697799+7bfe889e96ecfdeb8ab0a74860048ed9+llm_generated+aimeTagAnalysis+0+0.04344411566853523+3",3,"recommend_query_list","ztxxx06c0a024223920bbbeb1e0926","send_text","item_type","rec_info","display_text","rec_reason","root","relative","iwencai\u002FrecommendList0326",Array(0),"\u002F"));</script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/b929a16.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/28ccbec.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/d9802b5.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/2077034.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/1e0f8d6.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/7a5f495.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/921844b.js" defer=""></script>